Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

ENTEROMEDICS INC (ETRM)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 1,40 M
EBIT 2017 -26,2 M
Net income 2017 -27,1 M
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 -
Capi. / Sales2017 33,6x
Capi. / Sales2018 -
Capitalization 47,0 M
More Financials
Company
ReShape Lifesciences Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases.Its products include the ReShape Dual Balloon, vBloc Neurometabolic Therapy, and Gastric Vest System.The company was founded on December 2002 and is headquartered in... 
More about the company
Latest news on ENTEROMEDICS INC
2017 RESHAPE LIFESCIENCES INC. : Submission of Matters to a Vote of Security Holders,..
2017 RESHAPE LIFESCIENCES : Financial Statements and Exhibits (form 8-K/A)
2017 RESHAPE LIFESCIENCES : Announces Coverage of ReShape Dual Balloon by Major Telec..
2017 RESHAPE LIFESCIENCES INC. : Results of Operations and Financial Condition, Finan..
2017 RESHAPE LIFESCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
2017 ENTEROMEDICS ANNOUNCES NAME CHANGE T : Rsls
2017 RESHAPE LIFESCIENCES INC. : Amendments to Articles of Inc. or Bylaws; Change in ..
2016 ENTEROMEDICS INC : REVERSE SPLIT: 1 for 15; Reverse Split: 1 for 7
2016 ENTEROMEDICS : Announces Publication in SOARD of ASMBS Position Statement on Vag..
2015 ENTEROMEDICS : Reports Third Quarter 2015 Financial Results and Commercial Progr..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/16 Siemens' Healthineers in pre-IPO cost-cutting drive
01/09 BOSTON SCIENTIFIC : Health Care Up On Earnings Optimism -- Health Care Roundup
01/03 Akzo Nobel appoints Arcadis's Vree as CFO of chemicals business
2017 ROYAL PHILIPS : Philips Buys VitalHealth for Undisclosed Sum
2017 SAFRA CATZ : Oracle's Safra Catz among two new members named to Disney board
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
2016 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus BUY
Number of Analysts 1
Average target price 6,50 $
Spread / Average Target 314%
Managers
NameTitle
Dan W. Gladney Chairman, President & Chief Executive Officer
Peter M. Delange Senior VP-Operations & Business Development
Scott P. Youngstrom Secretary, CFO & Compliance Officer
Michael Y. Mashaal Director
Gary D. Blackford Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ENTEROMEDICS INC53.73%47
THERMO FISHER SCIENTIFIC11.38%85 167
DANAHER7.29%69 950
INTUITIVE SURGICAL18.13%48 542
ROYAL PHILIPS4.11%38 614
BOSTON SCIENTIFIC CORPORATION9.92%37 969